The Effects of Ripasudil in Patients With Fuchs Endothelial Corneal Dystrophy Undergoing Femtosecond Laser Assisted Cataract Surgery
The purpose of this research is to investigate the effects of ripasudil administered as an ophthalmic solution in patients with FED after femtosecond laser assisted cataract surgery. The secondary aim is to identity the characteristics of patients who will benefit the most with the use of ripasudil based on the test results obtained from this study.
• Patients with FED who will be listed for cataract surgery as part of standard clinical practice (A cataract will be defined as clouding of the lens that interferes with normal vision).
• Only patients older than 50 years will be included, as cataracts develops with increasing age. No gender criteria are applied.
• Ability to provide informed consent, and are willing and able to sign a written Informed Consent Form prior to any study-specific procedures.
• Patients must be willing and able to return for scheduled follow-up examinations for up to 12 months after the surgery.